iShares Core MSCI Emerging Markets ETF news

Highlighted as another strong alternative with low expense ratio (0.09%) and the largest asset base ($145.97B) among the alternatives mentioned, offering cheaper and lower-risk exposure to emerging markets.

IEMG is presented as the superior choice for long-term investors due to its significantly lower expense ratio (0.09%), higher dividend yield (2.4%), broader diversification with 2,853 holdings, and better 5-year total return performance ($1,376 vs $1,341).

IEMG has substantially outperformed SCHE over the last 12 months (30.7% vs 16.5%) and slightly outpaced it in five-year growth ($1,484 vs $1,348 on $1,000 invested). However, it carries higher volatility and expense ratio, making it better for growth-oriented investors with higher risk tolerance.

IEMG is recommended as the better buy for investors seeking emerging market exposure due to lower expense ratio (0.09%), higher dividend yield (2.3%), stronger 1-year returns (33.4%), and true diversification from U.S. markets with exposure to China, India, Taiwan, and South Korea.

Delivered exceptional 1-year return (35.7%) and 3-year annualized return (22.6%), outperforming VXUS in recent periods. Provides targeted exposure to high-growth emerging markets with significant technology tilt. However, carries higher expense ratio (0.09%) and steeper drawdown risk (-34.2%).

IEMG is presented as the superior choice for most investors due to its significantly lower expense ratio (0.09% vs 0.72%), higher dividend yield (2.6% vs 2.1%), broader portfolio with 2,725 holdings including small-caps, and comparable five-year risk-adjusted returns despite lower one-year performance.

Highlighted as a competitive alternative with low expense ratio (0.09%), substantial assets ($147.38 billion), and recommended as a cheaper option for investors seeking lower-risk traditional market-cap weighted exposure.

Recommended as an alternative with lower expense ratio (0.09% vs 0.58%), largest asset base ($147.38 billion), and positioned as a better choice for cost-conscious investors.

Presented as attractive for growth potential with substantial semiconductor exposure and participation in AI infrastructure buildout, but carries higher risks including currency fluctuations, geopolitical uncertainty, and heavy technology concentration (42%), making it less suitable for conservative long-term investors.

Presented as another strong alternative with low expense ratio (0.09%), the largest asset base ($147.91 billion), and broad market cap-weighted exposure, recommended for investors seeking cheaper and lower-risk options.

Recommended to avoid; emerging markets projected to underperform developed markets in the AI economy due to lower readiness for AI adoption.

Recommended as an alternative option with very low expense ratio (0.09%), largest asset base ($153.53 billion), and traditional market cap weighted strategy offering better value than TLTE.

Presented as a competitive alternative with low expense ratio of 0.09% and the largest asset base of $157.56 billion among the alternatives mentioned, suitable for investors preferring traditional market cap weighted strategies.

IEMG is presented as another attractive alternative with a low expense ratio (0.09%), substantial assets ($161.41 billion), and is recommended alongside VWO as a cost-effective option for traditional emerging market exposure.

Recommended as an alternative to PIE with very low expense ratio of 0.09%, substantial assets ($164.65 billion), and lower risk. Positioned as a preferable option for investors seeking cheaper, lower-risk exposure to emerging markets.

Strong recent performance with 43% returns over the past year, attractive valuations, and exposure to high-growth economies like Taiwan, South Korea, and India. The AI buildout is expected to continue driving returns.

Recommended for emerging market exposure with low fees.

IEMG has returned 44% in the past 12 months, tripled SPY's performance year-over-year, and recently broke through early-2021 peaks. Technical analysis suggests further upside with price targets around $98, and the rally appears to be in early stages with strong relative strength.